Cases and Deals

Blank Rome Represents Wedgewood Pharmacy in Majority Equity Investment by New Harbor Capital

Deal

Blank Rome successfully represented Wedgewood Pharmacy, the largest U.S. compounding pharmacy specializing in animal health, addiction medicine, and urology, in connection with a majority equity investment by New Harbor Capital, a Chicago-based private equity firm.

Wedgewood Pharmacy, based in Swedesboro, NJ, prepares customized medications for people and their pets when FDA-manufactured drugs cannot meet their needs. The company serves more than 36,000 prescribers and hundreds of thousands of patients throughout the United States. New Harbor Capital invests in lower middle market, growth-oriented business services, healthcare, and education companies.

To read Wedgewood’s press release and learn more about this transaction, please click here.

The Blank Rome team was led by Alan Zeiger, and included Cory Jacobs, Alex Tablin-Wolf, and Megan Filoon.

Wedgewood Pharmacy is the largest U.S. compounding pharmacy specializing in animal health, addiction medicine, and urology. Based in Swedesboro, NJ, Wedgewood prepares customized medications for people and their pets when FDA-manufactured drugs cannot meet their needs.